National Key R&D Program of China(2020YFC0860900);Emergency Key Program of Guangzhou Laboratory(EKPG21-30-4).
Background Whether methylprednisolone therapy can reduce the mortality rate of patients with severe coronavirus disease 2019(COVID-19)remains controversial,and its effects on the length of hospital stay and virus shed...
supported by grants from the National Key R&D Program of China(2020YFC0860900);the Emergency Key Program of Guangzhou Laboratory(EKPG21-30-4).
Background:The benefits and harms of methylprednisolone treatment in patients with moderate coronavirus disease 2019(COVID-19)remain controversial.In this study,we investigated the effect of methylprednisolone on mort...
Objective: To study the effect of methylprednisolone (MP) on reperfusion injury in severe uncontrolled hemorrhagic shock and explore the possible mechanism involved. Methods: Twelve dogs were randomly divided into two...